SCHEMBL8397283

SCHEMBL8397283

N=C(N)N(c1ccc2cccc3c2c1C(Br)=C3)C1C2CC3CC(C2)CC1C3

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8428364 0.77 MEN1 (0.40) MEN1MAPTMAPK1KMT2A
SCHEMBL6156344 0.72
SCHEMBL6155659 0.72 EPHX2 (0.33) MEN1MAPTMAPK1KMT2A
SCHEMBL8398462 0.66
SCHEMBL8400958 0.66
SCHEMBL8843240 0.66 SIGMAR1 (0.41)
SCHEMBL9316000 0.66 SIGMAR1 (0.41)
SCHEMBL6156028 0.64 MAPT (0.41) MEN1MAPTMAPK1KMT2A
SCHEMBL8401612 0.63 KDM4E (0.35) MEN1MAPTKMT2A
SCHEMBL8428530 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0918460-A1 METHODS OF TREATMENT OF EYE TRAUMA AND DISORDERS CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-06-02 EP disclosed
WO-1998004131-A1 METHODS OF TREATMENT OF EYE TRAUMA AND DISORDERS CAMBRIDGE NEUROSCIENCE, INC. (US) 1998-02-05 WO disclosed